Healthcare Sector

MRNA

Market Tracker

$65.61
-2.41
(-3.54%)
1:20 am
Next Earnings: (est.) 08/04/23 12:00 am
  • MRNA (Selected)

    Moderna, Inc.

MRNA Support / Resistance Levels

Loading Data..
WhaleStream

15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.

MRNA Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

MRNA Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

MRNA Dark Pool and Public Equity Key Price Levels

Loading Data..

Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.

MRNA Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

MRNA Largest 1-Day Open Interest Movements

Expires Type Strike OI Change Percent
09/20/2024 PUT $66.00 2,008 +1,412 +236.91%
11/15/2024 CALL $80.00 1,723 +1,021 +145.44%
09/20/2024 CALL $71.00 1,714 +924 +116.96%
09/27/2024 PUT $60.00 1,466 +765 +109.13%
09/27/2024 CALL $70.00 1,522 +661 +76.77%
10/18/2024 PUT $70.00 3,663 +639 +21.13%
09/20/2024 PUT $90.00 127 -546 -81.13%
09/20/2024 PUT $80.00 442 -864 -66.16%
10/18/2024 PUT $100.00 332 -1,088 -76.62%
01/17/2025 PUT $125.00 528 -1,114 -67.84%
09/20/2024 PUT $75.00 279 -1,437 -83.74%
01/17/2025 PUT $130.00 966 -1,879 -66.05%

Contracts with largest changes in open interest from the previous trading day to the current/most recent.

MRNA Major Holders

Name Pct Held Shares Total
Vanguard Total Stock Market Index Fund 2.57% 9.93M 1.25B
Vanguard International Growth Fund 2.53% 9.77M 1.23B
Vanguard 500 Index Fund 1.98% 7.64M 961.76M
Invesco ETF Tr-Invesco QQQ Tr, Series 1 ETF 1.31% 5.08M 639.64M
Fidelity 500 Index Fund 0.94% 3.62M 456.08M
SPDR S&P 500 ETF Trust 0.92% 3.57M 449.61M
Vanguard Specialized-Health Care Fund 0.90% 3.49M 439.87M
Growth Fund Of America Inc 0.80% 3.11M 391.58M
iShares Core S&P 500 ETF 0.76% 2.95M 371.32M
Vanguard U.S. Growth Fund 0.75% 2.88M 362.55M

MRNA News

  • Squamous Cell Carcinoma Clinical Trial Pipeline Insights: 75+ Key Companies Investigating Their Lead Candidates to Improve the Treatment Space | DelveInsight

    09/20 01:00 pm

    GlobeNewswire Inc.

    Read more
  • Down 13% in 1 Day, Is Moderna Stock in Trouble?

    09/20 05:52 am

    The Motley Fool

    Read more
  • Novo Nordisk Just Took a $530 Million Step Onto Moderna's Turf. Here's What It Means for Both Stocks

    09/19 06:50 am

    The Motley Fool

    Read more
  • Moderna, Inc. REMINDER – MRNA Stockholders Should Contact Robbins LLP for Information About the Moderna, Inc. Class Action and Pending Lead Plaintiff Deadline

    09/18 06:48 pm

    GlobeNewswire Inc.

    Read more
  • Prediction: These Could Be the Best-Performing Biotech Stocks Through 2030

    09/18 05:49 am

    The Motley Fool

    Read more
  • S&P 500 Briefly Hits Record High Just Ahead Of Fed Rate Cut, Extends 7-Day Winning Streak: Tuesday's Top 5 Gainers

    09/17 04:37 pm

    Benzinga

    Read more
  • Small Caps, Bitcoin Rally As Traders Await Fed Rate Cut; Treasury Yields, US Dollar Tick Up On Strong Retail Sales: What's Driving Markets Tuesday?

    09/17 01:37 pm

    Benzinga

    Read more
  • MRNA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Moderna, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

    09/16 04:00 pm

    GlobeNewswire Inc.

    Read more
  • Moderna, Tyson Foods And Adobe Are Among Top 10 Large Cap Stock Losers Last Week (Sep 8-Sep 14): Are The Others In Your Portfolio?

    09/15 06:44 pm

    Benzinga

    Read more
  • Down More Than 50%, Is It Time to Buy Moderna Stock as the Biotech Charts a New Post-COVID Path?

    09/15 08:20 am

    The Motley Fool

    Read more
  • Investing in Biotech or Pharma Stocks? Pay Attention to These 3 Things and You'll Win More

    09/14 09:15 am

    The Motley Fool

    Read more
  • ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Moderna, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRNA

    09/14 08:38 am

    GlobeNewswire Inc.

    Read more
  • Moderna Faces Analyst Downgrades Amid Revised R&D Restructured Strategy and Delayed Profitability Target

    09/13 06:34 pm

    Benzinga

    Read more
  • NCLA Suit Demands End to Gov’t Censorship of Support Groups for Victims of Covid Vaccine Injuries

    09/13 01:55 pm

    GlobeNewswire Inc.

    Read more
  • Should You Buy Novavax Stock After This Regulatory Win?

    09/13 07:50 am

    The Motley Fool

    Read more
  • A Bull Market Is Here: 2 High-Potential Stocks Down More Than 50% to Buy Right Now

    09/13 07:30 am

    The Motley Fool

    Read more
  • Moderna: Can the Strategic Focus Shift Revive Investor Confidence?

    09/13 02:25 am

    Investing.com

    Read more
  • Stocks Edge Up As Producer Inflation Supports Rate Cut Bets, Small Caps, Miners Rally: What's Driving Markets Thursday?

    09/12 01:34 pm

    Benzinga

    Read more
  • GSK Halts Herpes Simplex Virus Vaccine Development, Clears Path For Other Contenders Like Moderna, BioNTech

    09/11 12:13 pm

    Benzinga

    Read more
  • MRNA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Moderna, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

    09/10 04:00 pm

    GlobeNewswire Inc.

    Read more
  • Should You Buy Stocks in September? Here's What History Says.

    09/10 04:35 am

    The Motley Fool

    Read more
  • Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Moderna, Lululemon, XPEL, and Nano Nuclear and Encourages Investors to Contact the Firm

    09/09 09:00 pm

    GlobeNewswire Inc.

    Read more
  • Wall Street Rallies After Last Week's Sell-Off, Palantir Soars On S&P 500 Inclusion, Airlines Rally: What's Driving Markets Monday?

    09/09 01:35 pm

    Benzinga

    Read more
  • Why Is Moderna Stock Trading Higher On Monday?

    09/09 01:00 pm

    Benzinga

    Read more
  • Is It Time to Buy August's Worst-Performing Nasdaq Stocks?

    09/07 04:31 am

    The Motley Fool

    Read more
  • Moderna's Investigational Mpox Vaccine More Effective Than Current Approved Shot, Animal Study Shows

    09/06 02:02 pm

    Benzinga

    Read more
  • Could This Be the Catalyst Novavax Needs to Get Its Stock Rallying Again?

    09/05 10:00 am

    The Motley Fool

    Read more
  • Moderna, Inc. Shareholders - Robbins LLP Reminds MRNA Stockholders of the Class Action Lawsuit Against the Company – Seek Counsel Today

    09/04 10:54 pm

    GlobeNewswire Inc.

    Read more
  • MRNA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Moderna, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

    09/04 04:00 pm

    GlobeNewswire Inc.

    Read more
  • MODERNA, INC. (NASDAQ: MRNA) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Moderna, Inc. Investors of Upcoming Deadline

    09/03 01:45 am

    GlobeNewswire Inc.

    Read more
  • MRNA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Moderna, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

    08/29 04:00 pm

    GlobeNewswire Inc.

    Read more
  • Moderna And BioNTech Bet On Personalized Cancer Vaccines To Revive Fortunes After Dwindling COVID-19 Vaccine Sales

    08/29 12:01 pm

    Benzinga

    Read more
  • 3 Ways the Democratic Party's Platform Could Impact Biotech and Pharma Stocks if Implemented

    08/27 09:45 am

    The Motley Fool

    Read more
  • Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Moderna, PDD Holdings, Extreme Networks, and Sprinklr and Encourages Investors to Contact the Firm

    08/26 09:00 pm

    GlobeNewswire Inc.

    Read more
  • ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Moderna, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRNA

    08/24 04:27 pm

    GlobeNewswire Inc.

    Read more
  • Wall Street Predicts That This Stock Could Skyrocket by 65%: Time to Buy?

    08/24 11:20 am

    The Motley Fool

    Read more
  • ROSEN, LEADING INVESTOR COUNSEL, Encourages Moderna, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRNA

    08/20 11:41 pm

    GlobeNewswire Inc.

    Read more
  • MNRA STOCK NEWS: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Moderna, Inc. Class Action

    08/20 08:08 pm

    GlobeNewswire Inc.

    Read more
  • Pfizer and BioNTech's Combo Shot Missed the Mark. Is It Time to Sell?

    08/19 04:07 am

    The Motley Fool

    Read more
  • ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Moderna, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRNA

    08/16 05:36 pm

    GlobeNewswire Inc.

    Read more
  • MRNA Investors Have Opportunity to Lead Moderna, Inc. Securities Fraud Lawsuit with the Schall Law Firm

    08/14 12:50 pm

    GlobeNewswire Inc.

    Read more
  • ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Moderna, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – MRNA

    08/12 02:30 pm

    GlobeNewswire Inc.

    Read more
  • Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Moderna Inc. (MRNA)

    08/12 01:55 pm

    GlobeNewswire Inc.

    Read more
  • Glp-1 Analogues Market Size & Share to be Worth USD 606.3 Billion by 2034, at 33% CAGR: Prophecy Market Insights

    08/12 03:50 am

    GlobeNewswire Inc.

    Read more
  • Biogen (BIIB) Q2 Earnings & Sales Beat, 2024 Guidance Raised

    08/01 12:25 pm

    Zacks Investment Research

    Read more
  • SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA

    07/26 10:37 am

    GlobeNewswire Inc.

    Read more
  • Check Out What Whales Are Doing With MRNA - Benzinga

    07/22 11:46 am

    Benzinga

    Read more
  • Moderna director Afeyan sells over $1.8m in company stock By Investing.com - Investing.com Australia

    07/19 07:34 pm

    Investing.com

    Read more
  • Decoding Moderna's Options Activity: What's the Big Picture? - Benzinga

    07/19 10:34 am

    Benzinga

    Read more
  • Merck (MRK) Up 17% YTD on Keytruda Strength: Should You Buy? - Zacks Investment Research

    07/16 11:00 am

    Zacks Investment Research

    Read more
👀

Follow the Whales in real-time.

🎁

Take 50% OFF With Code: